Theoretically, prognostic, and predictive scores based on blood tests may include tumor related biomarkers such as CA 19-9 or CA-125, nucleic acid-based markers (e.g., circulating tumor DNA or circulating RNA), inflammatory, hematological and organ related markers (e.g., C-reactive protein, hemoglobin, albumin), or a combination of several. This evidence concerns the gene CRP and neoplasm.